Shares of several technology companies are trading higher amid market strength following positive data from a study of Gilead's Remdesivir, which is being evaluated for coronavirus. A successful treatment could mean a sooner return to economic activity. NOTE: Some names may also be moving in sympathy following recent earnings from Google and some semiconductor companies.
Benzinga Newsdesk